Jeff Bezos wants to delay ageing, quite literally. Multi-billionaire has become an investor in Altos Labs, an anti-aging technology startup, reports MIT Tech Review.
Altos Labs is studying the aging process and developing technology that can reprogram human cells to combat aging. The research is based on the developments of the Japanese scientist Yamanaka Shinyi, who received the Nobel Prize for his discoveries.
The center’s specialists plan to create a way to extend human life by 50 years.
Little is known about the company. The report said the start-up was set in the US and UK this year following a biotechnology-oriented conference that was held in the Los Altos Hills.
According to the MIT Tech Review, a securities disclosure filed in California in June indicates the company has raised at least $270 million (€227 million).
The company also reportedly plans to set up in multiple locations including San Diego, Japan, and Cambridge in the UK.
Bezos is said to have a fairly long-standing interest in longevity research, and he previously invested in an anti-aging company called Unity Biotechnology.
Do you think it’s a noble goal to pursue immortality? We would love to hear in the comments.
